Funding
Strategic · Healthtech

H1 receives $40m strategic investment from CVS Health Ventures

The investment backs healthcare-provider information for pharma, hospital and insurer customers.

Updated Oct 16, 2026By RoundOS Funding desk

H1 received a $40 million strategic investment from CVS Health Ventures on May 28. The company supplies information about doctors to pharmaceutical companies, hospital systems and health insurers.

Funding history

Strategic · This round$40M

Sources

  1. H1projectstartups.com
  2. techcrunch.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026

Related